These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21269601)

  • 1. Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor.
    Fink-Jensen A; Schmidt LS; Dencker D; Schülein C; Wess J; Wörtwein G; Woldbye DP
    Eur J Pharmacol; 2011 Apr; 656(1-3):39-44. PubMed ID: 21269601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4.
    Karasawa H; Taketo MM; Matsui M
    Eur J Pharmacol; 2003 May; 468(1):15-9. PubMed ID: 12729838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes.
    Erosa-Rivero HB; Bata-García JL; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL
    Neuropharmacology; 2014 Jun; 81():176-87. PubMed ID: 24534110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice.
    Thomsen M; Wess J; Fulton BS; Fink-Jensen A; Caine SB
    Psychopharmacology (Berl); 2010 Feb; 208(3):401-16. PubMed ID: 20013114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of muscarinic acetylcholine receptors facilitates motivated behaviour and rescues a model of antipsychotic-induced amotivation.
    Hailwood JM; Heath CJ; Phillips BU; Robbins TW; Saksida LM; Bussey TJ
    Neuropsychopharmacology; 2019 May; 44(6):1068-1075. PubMed ID: 30478410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice.
    Arora D; Mudgal J; Nampoothiri M; Mallik SB; Kinra M; Hall S; Anoopkumar-Dukie S; Grant GD; Rao CM
    Metab Brain Dis; 2018 Aug; 33(4):1045-1051. PubMed ID: 29516413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
    Wadenberg ML; Fjällström AK; Federley M; Persson P; Stenqvist P
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):644-54. PubMed ID: 20701827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Haloperidol-Induced Catalepsy by GPR143, an L-Dopa Receptor, in Striatal Cholinergic Interneurons.
    Arai M; Suzuki E; Kitamura S; Otaki M; Kanai K; Yamasaki M; Watanabe M; Kambe Y; Murata K; Takada Y; Arisawa T; Kobayashi K; Tajika R; Miyazaki T; Yamaguchi M; Lazarus M; Hayashi Y; Itohara S; de Kerchove d'Exaerde A; Nawa H; Kim R; Bito H; Momiyama T; Masukawa D; Goshima Y
    J Neurosci; 2024 Mar; 44(11):. PubMed ID: 38286627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
    Mandhane SN; Chopde CT; Ghosh AK
    Eur J Pharmacol; 1997 Jun; 328(2-3):135-41. PubMed ID: 9218695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of NR-ANX-C (a polyherbal formulation) on haloperidol induced catalepsy in albino mice.
    Nair V; Arjuman A; Dorababu P; Gopalakrishna HN; Chakradhar Rao U; Mohan L
    Indian J Med Res; 2007 Nov; 126(5):480-4. PubMed ID: 18160755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of a subpopulation of neuronal M4 muscarinic acetylcholine receptors in the antipsychotic-like effects of the M1/M4 preferring muscarinic receptor agonist xanomeline.
    Dencker D; Wörtwein G; Weikop P; Jeon J; Thomsen M; Sager TN; Mørk A; Woldbye DP; Wess J; Fink-Jensen A
    J Neurosci; 2011 Apr; 31(16):5905-8. PubMed ID: 21508215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.
    Byun NE; Grannan M; Bubser M; Barry RL; Thompson A; Rosanelli J; Gowrishankar R; Kelm ND; Damon S; Bridges TM; Melancon BJ; Tarr JC; Brogan JT; Avison MJ; Deutch AY; Wess J; Wood MR; Lindsley CW; Gore JC; Conn PJ; Jones CK
    Neuropsychopharmacology; 2014 Jun; 39(7):1578-93. PubMed ID: 24442096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.
    Watt ML; Rorick-Kehn L; Shaw DB; Knitowski KM; Quets AT; Chesterfield AK; McKinzie DL; Felder CC
    Neuropsychopharmacology; 2013 Dec; 38(13):2717-26. PubMed ID: 23907402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
    Auclair AL; Kleven MS; Barret-Grévoz C; Barreto M; Newman-Tancredi A; Depoortère R
    Behav Brain Res; 2009 Nov; 203(2):288-95. PubMed ID: 19464324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy.
    Prinssen EP; Colpaert FC; Koek W
    Eur J Pharmacol; 2002 Oct; 453(2-3):217-21. PubMed ID: 12398907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy.
    Naidu PS; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2004 Jun; 26(5):323-6. PubMed ID: 15319809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotarod impairment: catalepsy-like screening test for antipsychotic side effects.
    Kirschbaum KM; Hiemke C; Schmitt U
    Int J Neurosci; 2009; 119(10):1509-22. PubMed ID: 19922371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.